Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease

AIM: Several pathophysiological processes are involved in Parkinson’s disease (PD) and could inform in vivo biomarkers. We assessed an established biomarker panel, validated in Alzheimer’s Disease, in a PD cohort. METHODS: Longitudinal cerebrospinal fluid (CSF) samples from PPMI (252 PD, 115 healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartl, Michael, Dakna, Mohammed, Galasko, Douglas, Hutten, Samantha J., Foroud, Tatiana, Quan, Marian, Marek, Kenneth, Siderowf, Andrew, Franz, Jonas, Trenkwalder, Claudia, Mollenhauer, Brit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496858/
https://www.ncbi.nlm.nih.gov/pubmed/34618817
http://dx.doi.org/10.1371/journal.pone.0257372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496858/
https://www.ncbi.nlm.nih.gov/pubmed/34618817
http://dx.doi.org/10.1371/journal.pone.0257372

Ejemplares similares